Abstract
BackgroundEtanercept is a tumour necrosis factor (TNF) inhibitor indicated for active rheumatoid arthritis (RA) as monotherapy or in combination with methotrexate. Biosimilar drugs currently commercialised are Benepali and Erelzi.PurposeTo evaluate...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have